R Korolkiewicz
Overview
Explore the profile of R Korolkiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurczak W, Zinzani P, Gaidano G, Goy A, Provencio M, Nagy Z, et al.
Ann Oncol
. 2018 Feb;
29(5):1266-1272.
PMID: 29444231
Background: This two-stage, phase IIa study investigated the antitumor activity and safety of MOR208, an Fc-engineered, humanized, CD19 antibody, in patients with relapsed or refractory (R-R) B-cell non-Hodgkin's lymphoma (NHL)....
2.
Korolkiewicz R, Sein-Anand J
Colorectal Dis
. 2007 Jul;
9(9):856-7.
PMID: 17608819
No abstract available.
3.
Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R, Takeuchi K
Pharmacol Res
. 2000 Feb;
40(6):517-24.
PMID: 10660951
Roles of enterobacteria, nitric oxide (NO) and neutrophil in indomethacin-induced small intestinal lesions were examined in rats. Indomethacin (10 mg kg-1), administered s.c. as a single injection, caused haemorrhagic lesions...
4.
Korolkiewicz R, Tashima K, Kubomi M, Kato S, Takeuchi K
Digestion
. 1999 Nov;
60(6):528-37.
PMID: 10545722
Background: We investigated the mechanisms responsible for the increased susceptibility of diabetic rat gastric mucosa to damage inflicted by overnight food deprivation (18 h) and its worsening by the cold...
5.
Mlynarczyk M, Tutka P, Zolkowska D, Korolkiewicz R, Kleinrok Z
Pol J Pharmacol
. 1999 Jul;
51(1):106.
PMID: 10532803
No abstract available.
6.
Tashima K, Korolkiewicz R, Kubomi M, Takeuchi K
Br J Pharmacol
. 1998 Sep;
124(7):1395-402.
PMID: 9723950
1. We examined the gastric mucosal blood flow (GMBF) and ulcerogenic responses following barrier disruption induced by sodium taurocholate (TC) in diabetic rats and investigated the role of capsaicin-sensitive sensory...
7.
Korolkiewicz R, Mlynarczyk M, Gasior M, Kleinrok Z
Pharmacol Res
. 1998 Aug;
37(6):477-83.
PMID: 9695121
The dose to the intracerebroventricularly administered (i.c.v.) tetanus toxin (Tetx) evoking the death of 50% of experimental mice (LD50) was estimated to be 18.0 (11.5-28.2) times the minimal lethal dose...
8.
Korolkiewicz R, Rekowski P, Szyk A, Kato S, Yasuhiro T, Kubomi M, et al.
Pharmacology
. 1998 Aug;
57(2):65-78.
PMID: 9691226
The role of the cholinergic and peptidergic pathways in the impairment of gastric motility associated with diabetic gastroparesis was assessed at the postsynaptic level using isolated fundus smooth muscle strips....
9.
Kato S, Korolkiewicz R, Rekowski P, Szyk A, SUGAWA Y, Takeuchi K
Regul Pept
. 1998 Jul;
74(1):53-9.
PMID: 9657360
Inhibitory effect of galanin on basal and secretagogs-stimulated gastric acid secretion was investigated in urethane-anesthetized rats. A rat stomach was mounted in an ex-vivo chamber, perfused with saline, and either...
10.
Korolkiewicz R, Sliwinski W, Rekowski P, Szyk A, Mucha P, Konstanski Z, et al.
Pharmacology
. 1997 Dec;
55(4):179-84.
PMID: 9396077
The study was undertaken to characterize the effects of the porcine galanin [pGal(1-29)-NH2] analogue [Lys14]pGal(1-15)-NH2 on rat gastric fundus. [Lys14]pGal(1-15)-NH2 is a less potent contractile agent than pGal(1-29)-NH2 (EC50 74.1...